Hazan, E., Bellavance, S., Lavigne, P., Christopoulos, A., & Tabet, P. (2025). Use of Rituximab in the Management of a Nasopharyngeal Fibrosing Inflammatory Pseudotumor. Clinical Case Reports, 13(9), 1. https://doi.org/10.1002/ccr3.70823
Chicago Style (17th ed.) CitationHazan, Erika, Samuel Bellavance, Philippe Lavigne, Apostolos Christopoulos, and Paul Tabet. "Use of Rituximab in the Management of a Nasopharyngeal Fibrosing Inflammatory Pseudotumor." Clinical Case Reports 13, no. 9 (2025): 1. https://doi.org/10.1002/ccr3.70823.
MLA (9th ed.) CitationHazan, Erika, et al. "Use of Rituximab in the Management of a Nasopharyngeal Fibrosing Inflammatory Pseudotumor." Clinical Case Reports, vol. 13, no. 9, 2025, p. 1, https://doi.org/10.1002/ccr3.70823.